You are here

  • Home
  • Archive
  • Volume 69, Issue 10
  • Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis

Citation Tools

Article menu
Download PDFPDF
PostScript
PostScript
Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Teng Y, Li M, Xiang B, et al
Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis
Gut 2020;69:1900-1902.